Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes

Journal of Clinical Oncology

Volumn 28, Issue 27, 2010, Pages 4177-4183

  Bazarbachi, Ali ^a   Plumelle, Yves ^a   Ramos, Juan Carlos ^a   Tortevoye, Patricia ^a   Otrock, Zaher ^a   Taylor, Graham ^a   Gessain, Antoine ^a   Harrington, William ^a   Panelatti, Gérard ^a   Hermine, Olivier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LAMIVUDINE; PREDNISONE; VINCRISTINE; VINDESINE; ZALCITABINE; ZIDOVUDINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; FEMALE; FRANCE; HAZARD RATIO; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; T CELL LEUKEMIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED KINGDOM; UNITED STATES; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; KAPLAN MEIER METHOD; MARTINIQUE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVOR; TIME; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; GREAT BRITAIN; HUMANS; INTERFERON-ALPHA; KAPLAN-MEIERS ESTIMATE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MARTINIQUE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT; ZIDOVUDINE;

EID: 77957962485     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.0669     Document Type: Article

References (25)

1. Hinuma Y, Komoda H, Chosa T, et al: Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study. Int J Cancer 29:631-635, 1982 (Pubitemid 12089201)
2. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma: A report from the Lymphoma Study Group (1984-1987). Br J Haematol 79:428-437, 1991
3. Takatsuki F, Yamaguchi K, Hattori T: Adult T-cell leukemia/lymphoma, in Gallo RC, Wong-Staal F (eds): Retrovirus Biology and Human Disease. New York, NY, Marcel Dekker, 1990, pp 147-159
4. Bazarbachi A, Ghez D, Lepelletier Y, et al: New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 5:664-672, 2004 (Pubitemid 40267851)
5. Shimoyama M: Treatment of patients with adult T-cell leukemia-lymphoma: An overview, in Takatsuki K, Hinuma Y, Yoshida M (eds): Advances in Adult T-Cell Leukemia and HTLV-I Research. Tokyo, Japan, Japan Scientific Societies, 1992, pp 43-56
6. Yamada Y, Tomonaga M, Fukuda H, et al: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001 (Pubitemid 32523141)
7. Hermine O, Wattel E, Gessain A, et al: Adult T cell leukaemia: A review of established and new treatments. BioDrugs 10:447-462, 1998 (Pubitemid 29013721)
8. Takasaki Y, Iwanaga M, Tsukasaki K, et al: Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL). Leuk Res 31:751-757, 2007 (Pubitemid 46855900)
9. Tsukasaki K, Hermine O, Bazarbachi A, et al: Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol 27:453-459, 2009
10. Gill PS, Harrington W Jr, Kaplan MH, et al: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744-1748, 1995
11. Hermine O, Bouscary D, Gessain A, et al: Brief report: Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749-1751, 1995
12. Bazarbachi A, Hermine O: Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 13:S186-S190, 1996 (suppl 1)
13. White JD, Wharfe G, Stewart DM, et al: The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma 40:287-294, 2001 (Pubitemid 32401385)
14. Hermine O, Allard I, Lévy V, et al: French ATL therapy group: A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. Hematol J 3:276-282, 2002 (Pubitemid 36163756)
15. Matutes E, Taylor GP, Cavenagh J, et al: Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: Response and outcome in 15 patients. Br J Haematol 113:779-784, 2001 (Pubitemid 32524403)
16. Ratner L, Harrington W, Feng X, et al: Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One 4:e4420, 2009
17. Besson C, Panelatti G, Delaunay C, et al: Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide. Leuk Lymphoma 43:2275-2279, 2002 (Pubitemid 35386150)
18. Tsukasaki K, Utsunomiya A, Fukuda H, et al: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458-5464, 2007 (Pubitemid 350232223)
19. Datta A, Bellon M, Sinha-Datta U, et al: Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108:1021-1029, 2006 (Pubitemid 44154640)
20. Ramos JC, Ruiz P Jr, Ratner L, et al: IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood 109:3060-3068, 2007 (Pubitemid 46482107)
21. Isono T, Ogawa K, Seto A: Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits. Leuk Res 14:841-847, 1990
22. Macchi B, Faraoni I, Zhang J, et al: AZT inhibits the transmission of human T cell leukaemia/ lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. J Gen Virol 78:1007-1016, 1997 (Pubitemid 27207586)
23. Bazarbachi A, Nasr R, El-Sabban ME, et al: Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma. Leukemia 14:716-721, 2000 (Pubitemid 30195465)
24. Feng X, Heyden NV, Ratner L: Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol 77:13389-13395, 2003 (Pubitemid 37494332)
25. Gessain A: Epidemiology of HTLV-I and associated diseases, in Höllsberg TP, Hafler DA (eds): Human T-cell Lymphotropic Virus Type 1. Chichester, United Kingdom, John Wiley and Sons, 1996, pp 33-64